Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (321-330 of 418) with videos related to

Pageof 42
Sort By:
Journal of Clinical Medicine|April 3, 2021
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line PembrolizumabEdoardo Lenci, Luca Cantini, Federica Pecci, et al.
International Journal of Molecular Sciences|May 26, 2019
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung TumorsAngelo Sparaneo, Federico Pio Fabrizio, Annamaria la Torre, et al.
Clinical Genitourinary Cancer|August 17, 2019
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018Laura Marandino, Emmanuele De Luca, Clizia Zichi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 6, 2019
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of lifeChiara Baratelli, Carmela Giovanna Cleopatra Turco, Gaetano Lacidogna, et al.
International Journal of Cancer|June 9, 2022
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trialAlessandra Raimondi, Giovanni Randon, Michele Prisciandaro, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective studyElisa Gobbini, Domenico Galetta, Marcello Tiseo, et al.
European Radiology|March 7, 2025
Multicenter external validation of a novel aggregated technique for percutaneous CT guided lung biopsy for multiple samplings: the ExtraPEARL studyMarco Calandri, Jacopo Brino, Steven Yevich, et al.
JAMA Network Open|April 9, 2024
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled TrialDavide Ciardiello, Erika Martinelli, Teresa Troiani, et al.
Cells|October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung CancerAnnapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Critical Reviews in Oncology/Hematology|August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
Pageof 42

Showing results (321-330 of 418) with videos related to

Sort By:
Pageof 42
Journal of Clinical Medicine|April 3, 2021
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line PembrolizumabEdoardo Lenci, Luca Cantini, Federica Pecci, et al.
International Journal of Molecular Sciences|May 26, 2019
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung TumorsAngelo Sparaneo, Federico Pio Fabrizio, Annamaria la Torre, et al.
Clinical Genitourinary Cancer|August 17, 2019
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018Laura Marandino, Emmanuele De Luca, Clizia Zichi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 6, 2019
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of lifeChiara Baratelli, Carmela Giovanna Cleopatra Turco, Gaetano Lacidogna, et al.
International Journal of Cancer|June 9, 2022
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trialAlessandra Raimondi, Giovanni Randon, Michele Prisciandaro, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective studyElisa Gobbini, Domenico Galetta, Marcello Tiseo, et al.
European Radiology|March 7, 2025
Multicenter external validation of a novel aggregated technique for percutaneous CT guided lung biopsy for multiple samplings: the ExtraPEARL studyMarco Calandri, Jacopo Brino, Steven Yevich, et al.
JAMA Network Open|April 9, 2024
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled TrialDavide Ciardiello, Erika Martinelli, Teresa Troiani, et al.
Cells|October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung CancerAnnapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Critical Reviews in Oncology/Hematology|August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
Pageof 42